Rizatriptan: here's the fair price
This is what US pharmacies pay, on average, for rizatriptan. Use it to spot a fair cash price, and feel good about asking for one.
Rizatriptan 10 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Rizatriptan 10 Mg Tablet. Pharmacies pay about $9.84 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| RIZATRIPTAN 10 MG TABLETGeneric | $0.33 per tablet or capsule | $9.84 | 10/21/2026 |
| RIZATRIPTAN 5 MG TABLETGeneric | $0.34 per tablet or capsule | $10.31 | 10/21/2026 |
| RIZATRIPTAN 10 MG ODTGeneric | $0.52 per tablet or capsule | $15.65 | 10/21/2026 |
| RIZATRIPTAN 5 MG ODTGeneric | $0.56 per tablet or capsule | $16.77 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS & USAGE Ri zatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use • Rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks. • Rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4) ]. • Rizatriptan...
Common side effects (FDA label)
6 ADVERSE REACTIONS The following adverse reactions are discussed in more detail in other sections of the labeling: • Myocardial Ischemia, Myocardial Infarction, and Prinzmetal's Angina [see Warnings and Precautions ( 5.1 )]. • Arrhythmias [see Warnings and Precautions ( 5.2 )]. • Chest, Throat, Neck and/or Jaw Pain/Tightness/Pressure [see Warnings and Precautions ( 5.3 )]. • Cerebrovascular Events [see Warnings and Precautions ( 5.4 )]. • Other Vasospasm Reactions [see Warnings and Precautions ( 5.5 )]. • Medication Overuse Headache [see Warnings and Precautions ( 5.6 )]. • Serotonin...
Drug interactions (from the label)
7 DRUG INTERACTIONS 7.1 Propranolol The dose of rizatriptan benzoate should be adjusted in propranolol-treated patients, as propranolol has been shown to increase the plasma AUC of rizatriptan by 70% [see Dosage and Administration ( 2.4 ) and Clinical Pharmacology ( 12.3 )] . 7.2 Ergot-Containing Drugs Ergot-containing drugs have been reported to cause prolonged vasospastic reactions. Because these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or methysergide) and rizatriptan benzoate within 24 hours is contraindicated [see Contraindications ( 4 )] . 7.3 Other 5-HT 1 Agonists Because their vasospastic effects may be additive,...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS • Myocardial ischemia, myocardial infarction, and Prinzmetal's angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors ( 5.1 ) • Arrhythmias: Discontinue dosing if occurs ( 5.2 ) • Chest/throat/neck/jaw pain, tightness, pressure, or heaviness; Generally not associated with myocardial ischemia; Evaluate patients at high risk ( 5.3 ) • Cerebral hemorrhage, subarachnoid hemorrhage, and stroke: Discontinue dosing if occurs ( 5.4 ) • Gastrointestinal ischemic events, peripheral vasospastic reactions: Discontinue dosing if occurs ( 5.5 ) • Medication overuse headache: Detoxification may be necessary ( 5.6 ) • Serotonin syndrome:...
Source: FDA drug label via openFDA, label effective 2022-07-01. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.